Syngene International is one of the biggest and emerging global CROs which provide end-to-end discovery, process development and manufacturing services in chemistry and biology sciences. The multi-disciplinary skills of Syngene were elaborated to integrated drug discovery and development includes medicinal chemistry, biology, in vivopharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing and formulation. In order to integrate the comprehensive capabilities to differentiate from competitors, Syngene has been forming multi-disciplinary teams that work cohesively, monitoring projects continuously and proactively addressing and resolving critical issues. Advanced analytics, sensors, and the automation of complex decisions are capable of delivering a step change in the efficiency, speed, quality, and responsiveness of business. Syngene is no exception. To thrive in a digital world, pharma companies will need to deploy next-generation technologies to streamline their business processes. They need to achieve near real-time transparency of their clinical-trials portfolio in R&D, and frictionless sales and operations planning in the supply chain, as well as meet new expectations in efficiency and agility from customers, employees, patients, and suppliers.